Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Haematologica
|
April 23, 2026
Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience
Gaetan Basile, Arnaud Neuville, Delphine Martineau, et al.
Haematologica
|
June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
Jean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Blood Advances
|
May 1, 2025
TRANSCAR: Real-World outcomes of CD19CAR T Cell Therapy in relapsed/refractory transformed indolent lymphomas
Pierre Stephan, Roberta Di Blasi, Louise Roulin, et al.
Blood Advances
|
August 14, 2020
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
American Journal of Hematology
|
November 18, 2024
Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries
Christian Récher, Pierre-Yves Dumas, Emilie Bérard, et al.
Blood
|
September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
Alexis Caulier, Murielle Roussel, Pierre Morel, et al.
Hemasphere
|
February 19, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
Jean Galtier, Charles Mesguich, Pierre Sesques, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2024
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
Cédric Rossi, Guillaume Manson, Amira Marouf, et al.
Transplantation and Cellular Therapy
|
February 27, 2023
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC
Eléonore Kaphan, François Bettega, Edouard Forcade, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2025
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines
Loïc Renaud, Marie Donzel, Justine Decroocq, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Haematologica
|
April 23, 2026
Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience
Gaetan Basile, Arnaud Neuville, Delphine Martineau, et al.
Haematologica
|
June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
Jean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Blood Advances
|
May 1, 2025
TRANSCAR: Real-World outcomes of CD19CAR T Cell Therapy in relapsed/refractory transformed indolent lymphomas
Pierre Stephan, Roberta Di Blasi, Louise Roulin, et al.
Blood Advances
|
August 14, 2020
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
American Journal of Hematology
|
November 18, 2024
Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries
Christian Récher, Pierre-Yves Dumas, Emilie Bérard, et al.
Blood
|
September 3, 2021
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
Alexis Caulier, Murielle Roussel, Pierre Morel, et al.
Hemasphere
|
February 19, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
Jean Galtier, Charles Mesguich, Pierre Sesques, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2024
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
Cédric Rossi, Guillaume Manson, Amira Marouf, et al.
Transplantation and Cellular Therapy
|
February 27, 2023
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC
Eléonore Kaphan, François Bettega, Edouard Forcade, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2025
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines
Loïc Renaud, Marie Donzel, Justine Decroocq, et al.
Page
of 3